Legal & General Group PLC Xeris Biopharma Holdings, Inc. Transaction History

Legal & General Group PLC

$390 Billion
Q2 2025

A detailed history of Legal & General Group PLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 1,804,203 shares of XERS stock, worth $17.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,804,203

Previous 1,411,614 27.81%

Holding current value

$17.6 Million

Previous $7.75 Million 8.72%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$3.95 - $5.16 $1.55 Million - $2.03 Million	392,589 Added 27.81%	1,804,203 $8.43 Million
Q1 2025 May 15, 2025	BUY	$3.2 - $5.95 $3.78 Million - $7.03 Million	1,181,147 Added 512.5%	1,411,614 $7.75 Million
Q4 2024 Feb 13, 2025	BUY	$2.78 - $3.73 $54,554 - $73,197	19,624 Added 9.31%	230,467 $781,000
Q3 2024 Feb 28, 2025	SELL	$2.06 - $2.96 $40,425 - $58,087	-19,624 Reduced 8.51%	210,843 $600,000
Q3 2024 Nov 14, 2024	BUY	$2.06 - $2.96 $403,704 - $580,080	195,973 Added 1317.91%	210,843 $600,000
Q2 2024 May 29, 2025	BUY	$1.7 - $2.45 $549 - $791	323 Added 2.22%	14,870 $33,000
Q2 2024 Aug 14, 2024	BUY	$1.7 - $2.45 $549 - $791	323 Added 2.22%	14,870 $33,000
Q1 2024 May 29, 2025	SELL	$2.04 - $3.22 $2.85 Million - $4.5 Million	-1,397,067 Reduced 98.97%	14,547 $32,000
Q4 2023 May 29, 2025	SELL	$1.47 - $2.36 $2.05 Million - $3.3 Million	-1,397,067 Reduced 98.97%	14,547 $34,000
Q4 2023 Feb 15, 2024	SELL	$1.47 - $2.36 $1,158 - $1,859	-788 Reduced 5.14%	14,547 $34,000
Q3 2023 Nov 14, 2023	SELL	$1.8 - $2.69 $2,381 - $3,558	-1,323 Reduced 7.94%	15,335 $28,000
Q2 2023 Aug 14, 2023	BUY	$1.82 - $2.98 $152 - $250	84 Added 0.51%	16,658 $43,000
Q3 2022 Nov 14, 2022	SELL	$1.37 - $1.93 $12,273 - $17,290	-8,959 Reduced 35.09%	16,574 $26,000
Q2 2022 Aug 22, 2022	BUY	$1.48 - $2.64 $37,788 - $67,407	25,533 New	25,533 $39,000

Others Institutions Holding XERS

# of Institutions

215

Shares Held

89.8M

Call Options Held

81.6K

Put Options Held

57.6K

View Full List

About Xeris Biopharma Holdings, Inc.

Ticker XERS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,956,992
Market Cap $1.33B
Description
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...

More about XERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Xeris Biopharma Holdings, Inc. Transaction History